Home/Cytoki Pharma/Martijn van de Bunt
MV

Martijn van de Bunt

Chief Scientific Officer

Cytoki Pharma

Cytoki Pharma Pipeline

DrugIndicationPhase
CK-0045Obesity and Type 2 DiabetesPhase 2